LivaNova share price logo

LivaNova

NASDAQ: LIVN

Mid Cap

$75.48

+0.41

(+0.55%)

Live

as on

LivaNova Stock Performance

as on October 6, 2026 at 1:08 am IST

  • Day's Low

    Day's High

    $74.42
    $75.76
    downward going graph

    1.40%

    Downside

    0.37%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $48.82
    $85.76
    downward going graph

    35.32%

    Downside

    13.62%

    Upside

    downward going graph

LivaNova share price movements today

Previous Close
$75.07
Open
$75.56
Volume
17.2K
Market Cap
$4.1B
Day's Low - High
$74.42 - $75.76
52 Week Low - High
$48.82 - $85.76

LivaNova Historical Returns

1 Month Return
-7.55 %
3 Month Return
-10.22 %
1 Year Return
+ 40.66 %
3 Year Return
+ 45.43 %
5 Year Return
-7.5 %

LivaNova Stock Fundamentals & Key Indicators

Check LivaNova market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$4.1B

EPS (TTM)

3.45

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

2.88%

PE Ratio (TTM)

21.7

Industry PE ratio

10.88

PEG Ratio

0.08

EBITDA

180.7M

Revenue (TTM)

1.5B

Profit Margin

68.18%

Return On Equity TTM

15.41%

LivaNova vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of LivaNova with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
StrongBuy$4.1B-7.50%21.7068.18%0.00%
Buy$49.0B-21.76%48.9477.98%0.00%
Buy$110.5B-31.34%21.1266.69%3.31%
StrongBuy$105.6B4.93%28.3165.17%1.28%
StrongBuy$168.7B-15.86%31.3556.80%2.54%

Stock Returns calculator for LivaNova Stock including INR - Dollar returns

The LivaNova stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

LivaNova investment value today

Current value as on today

₹1,53,497

Returns

₹53,497

(+53.5%)

Returns from LivaNova Stock

₹41,428 (+41.43%)

Dollar Impact

₹12,070 (+12.07%)

Analyst Recommendation on LivaNova Stock

Based on 3 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 3 analysts, 100% of analysts recommend a 'BUY' rating for LivaNova. Average target price of $89.1

LivaNova Share Price Target

Get share price movements and forecasts by analysts on LivaNova.

What analysts predicted

15.29%UPSIDE

Target Price

$89.1

Current Price

$75.48

Analyzed by

3 Analysts

High

$93

Target

$89.10

Low

$90

LivaNova target price $89.1, a slight upside of 15.29% compared to current price of $75.48. According to 3 analysts rating.

Indian Investors' Interest in LivaNova Stock

Search interest for LivaNova Stock has decreased by -49% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-49% versus previous 30 day period

LivaNova Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
294
318
318
321
316
352
357
360
362
390
Gross Profit
207
214
225
219
220
238
244
239
244
273
Operating Income
16
40
35
37
48
54
54
42
52
49
EBITDA
-5
49
73
84
-285
60
57
47
50
25
Interest Expense
15
15
15
15
15
12
10
19
8
7
Depreciation
13
12
13
12
14
15
12
0
15
-
Income Before Tax
-34
21
44
56
-315
33
33
27
26
18
Income Tax Expense
7
5
11
0
11
6
7
-3
4
-90
Net Income
-41
16
32
55
-327
27
26
30
22
108
Net Profit Margin
70.32%
67.45%
70.81%
68.16%
69.68%
67.79%
68.45%
66.45%
67.59%
70.07%

LivaNova Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
1,012
1,107
1,084
934
1,035
1,021
1,153
1,253
1,388
Gross Profit
651
734
723
594
705
707
771
870
939
Operating Income
95
-248
-171
-273
0
-76
-68
129
199
EBITDA
199
-167
119
6
-6
30
38
202
-129
Interest Expense
7
9
15
40
50
48
58
63
49
Depreciation
70
69
70
67
67
57
60
51
42
Income Before Tax
121
-247
-127
-348
-124
-75
-81
88
-220
Income Tax Expense
49
-69
-30
0
11
11
-98
25
21
Net Income
-25
-189
-157
-348
-135
-86
17
63
-242
Net Profit Margin
64.37%
66.35%
66.76%
63.66%
68.19%
69.21%
66.86%
69.48%
67.71%

LivaNova Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-41
16
32
55
-327
27
26
30
22
108
Operating Cash Flow
9
43
50
78
23
62
85
82
15
66
Investing Cash Flow
-6
-12
-18
-10
-10
-8
-23
-30
-14
-31
Financing Cash Flow
37
-11
-3
-3
-4
-208
-9
-62
-94
-56
Change in Cash
37
17
33
56
14
-144
52
-10
-95
-23

LivaNova Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-25
-189
-157
-345
-135
-86
17
63
-242
Operating Cash Flow
91
120
-91
-79
102
69
74
183
254
Investing Cash Flow
-52
-120
-41
-41
36
-38
-40
-48
-72
Financing Cash Flow
11
-42
146
310
-181
280
21
18
-285
Change in Cash
53
-46
13
191
-44
307
62
145
-88

Global Institutional Holdings in LivaNova

Check out the Institutions with significant holdings in LivaNova.

Funds
Holdings
iShares
12.23%
Theofanis Kolokotrones
7.57%
VANGUARD HORIZON FUNDS
4.33%
Avantis
3.42%
AIM Sector Funds (Invesco Sector Funds)
3.05%

Insights on LivaNova

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, LIVN has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, 22.30M → 108.60M (in $), with an average increase of 79.5% per quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 6 quarters, 316.85M → 390.60M (in $), with an average increase of 4.0% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 year, LIVN stock has moved up by 40.7%

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, LIVN has outperformed top 5 stocks with highest market-cap in its industry

About LivaNova

LivaNova PLC is a global medical technology company dedicated to developing, manufacturing, and marketing a variety of therapeutic solutions. The company operates through three key segments. Its Cardiopulmonary division provides essential products for heart-lung procedures, such as oxygenators, heart-lung machines, and various perfusion systems. The Neuromodulation segment is known for its VNS Therapy System, an implantable device that delivers vagus nerve stimulation to treat drug-resistant epilepsy, difficult-to-treat depression, and obstructive sleep apnea. This segment is also advancing the VITARIA System, which employs VNS for heart failure, through clinical development. The Advanced Circulatory Support segment offers temporary life support solutions, including both cardiopulmonary and respiratory support technologies. LivaNova serves a wide range of medical professionals, including perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals and healthcare providers. The company's products are distributed globally through both its direct sales force and independent distributors. Additionally, LivaNova has a research collaboration with Verily aimed at discovering clinical biomarkers for depression. Founded in 1987, the company is headquartered in London, United Kingdom.
OrganisationLivaNova
Headquarters5220 Valiant Court, Gloucester, GL, GL3 4FE, GB
IndustryMedical - Devices
CEOVladimir A. Makatsaria

Key Management of LivaNova

Name

Title

Mr. Alex Shvartsburg C.M.A.

Chief Financial Officer

Mr. Ahmet Tezel Ph.D.

Chief Innovation Officer

Ms. Lindsey Little

VP & Chief Accounting Officer

Deanna Wilke

Vice President of Corporate Communications

Mr. Vladimir A. Makatsaria

CEO & Director

Ms. Natalia Sergeyevna Kozmina

Chief Human Resources Officer

Briana Gotlin

Vice President of Investor Relations

Ms. Anne M. Liddy

Chief Legal Officer

Mr. Philip Kowalczyk

Chief Strategy & Corporate Development Officer

Mr. Paul R. Buckman

President of Advanced Circulatory Support & GM of Transcatheter Mitral Valve Replacement

FAQs

What is LivaNova share price today?

LivaNova share price today is $75.48 as on . LivaNova share today touched a day high of $75.76 and a low of $74.42.

What is the 52 week high and 52 week low for LivaNova share?

LivaNova share touched a 52 week high of $85.76 on and a 52 week low of $48.82 on . LivaNova stock price today i.e. is trending at $75.48,which is 11.99% down from its 52 week high and 54.61% up from its 52 week low.

What is LivaNova's market capitalisation today?

LivaNova market capitalisation is $0.00T as on .

How to invest in LivaNova Stock (LIVN) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for LivaNova on INDmoney app. Click on Buy button.

What is the minimum amount required to buy LivaNova Stock (LIVN) from India?

Indian investors can start investing in LivaNova (LIVN) shares with as little as ₹96.292503356934 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹962.93 in LivaNova stock (as per the Rupee-Dollar exchange rate as on ). Based on LivaNova share’s latest price of $75.48 as on October 5, 2026 at 7:38 pm IST, you will get 0.1325 shares of LivaNova. Learn more about fractional shares .

What are the returns that LivaNova has given to Indian investors in the last 5 years?

LivaNova stock has given -7.5% share price returns and 29.18% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?